BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Murta V, Villarreal A, Ramos AJ. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders? ASN Neuro 2020;12:1759091420954960. [PMID: 32878468 DOI: 10.1177/1759091420954960] [Cited by in Crossref: 38] [Cited by in F6Publishing: 46] [Article Influence: 12.7] [Reference Citation Analysis]
Number Citing Articles
1 Noda Y, Sato A, Shichi M, Sato A, Fujii K, Iwasa M, Nagano Y, Kitahata R, Osawa R. Real world research on transcranial magnetic stimulation treatment strategies for neuropsychiatric symptoms with long-COVID in Japan. Asian J Psychiatr 2022;81:103438. [PMID: 36610206 DOI: 10.1016/j.ajp.2022.103438] [Reference Citation Analysis]
2 Tsilioni I, Theoharides TC. Recombinant SARS-CoV-2 Spike Protein and its Receptor Binding Domain stimulate release of different pro-inflammatory mediators via activation of distinct receptors on  human microglia cells.. [DOI: 10.21203/rs.3.rs-2394904/v1] [Reference Citation Analysis]
3 Rossi E, Mutti L, Morrione A, Giordano A. Neuro–Immune Interactions in Severe COVID-19 Infection. Pathogens 2022;11:1256. [DOI: 10.3390/pathogens11111256] [Reference Citation Analysis]
4 Hogberg HT, Lam A, Ohayon E, Shahbaz MA, Clerbaux L, Bal-price A, Coecke S, Concha R, De Bernardi F, Edrosa E, Hargreaves AJ, Kanninen KM, Munoz A, Pistollato F, Saravanan S, Garcia-reyero N, Wittwehr C, Sachana M. The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19. Cells 2022;11:3411. [DOI: 10.3390/cells11213411] [Reference Citation Analysis]
5 Priya SP, Sunil PM, Varma S, Brigi C, Isnadi MFAR, Jayalal JA, Shadamarshan RA, Kumar SS, Kumari NV, Kumar RPR. Direct, indirect, post-infection damages induced by coronavirus in the human body: an overview. VirusDis 2022. [DOI: 10.1007/s13337-022-00793-9] [Reference Citation Analysis]
6 Tokic D, Mikacic M, Kumric M, Ticinovic Kurir T, Rancic I, Martinovic D, Bukic J, Vrdoljak J, Lizatovic IK, Stipic SS, Supe Domic D, Bozic J. Association between Brain Injury Markers and Testosterone in Critically-Ill COVID-19 Male Patients. Microorganisms 2022;10:2095. [DOI: 10.3390/microorganisms10112095] [Reference Citation Analysis]
7 Tziastoudi M, Cholevas C, Stefanidis I, Theoharides TC. Genetics of COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review. Ann Clin Transl Neurol 2022. [PMID: 36204816 DOI: 10.1002/acn3.51631] [Reference Citation Analysis]
8 Alvarez M, Trent E, Goncalves BDS, Pereira DG, Puri R, Frazier NA, Sodhi K, Pillai SS. Cognitive dysfunction associated with COVID-19: Prognostic role of circulating biomarkers and microRNAs. Front Aging Neurosci 2022;14:1020092. [DOI: 10.3389/fnagi.2022.1020092] [Reference Citation Analysis]
9 Łuc M, Woźniak M, Rymaszewska J. Neuroinflammation in Dementia—Therapeutic Directions in a COVID-19 Pandemic Setting. Cells 2022;11:2959. [DOI: 10.3390/cells11192959] [Reference Citation Analysis]
10 Lanoce E, Dumeng-rodriguez J, Christian KM. Using 2D and 3D pluripotent stem cell models to study neurotropic viruses. Front Virol 2022;2. [DOI: 10.3389/fviro.2022.869657] [Reference Citation Analysis]
11 Gonçalves C, Sesterheim P, Wartchow KM, Bobermin LD, Leipnitz G, Quincozes-santos A. Why antidiabetic drugs are potentially neuroprotective during the Sars-CoV-2 pandemic: The focus on astroglial UPR and calcium-binding proteins. Front Cell Neurosci 2022;16:905218. [DOI: 10.3389/fncel.2022.905218] [Reference Citation Analysis]
12 Thangaleela S, Sivamaruthi BS, Kesika P, Bharathi M, Chaiyasut C. Nasal Microbiota, Olfactory Health, Neurological Disorders and Aging—A Review. Microorganisms 2022;10:1405. [DOI: 10.3390/microorganisms10071405] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Velnar T, Bosnjak R. Management of neurosurgical patients during coronavirus disease 2019 pandemics: The Ljubljana, Slovenia experience. World J Clin Cases 2022; 10(15): 4726-4736 [DOI: 10.12998/wjcc.v10.i15.4726] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Seehusen F, Clark JJ, Sharma P, Bentley EG, Kirby A, Subramaniam K, Wunderlin-giuliani S, Hughes GL, Patterson EI, Michael BD, Owen A, Hiscox JA, Stewart JP, Kipar A. Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse. Viruses 2022;14:1020. [DOI: 10.3390/v14051020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
15 Renz-polster H, Tremblay M, Bienzle D, Fischer JE. The Pathobiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Case for Neuroglial Failure. Front Cell Neurosci 2022;16:888232. [DOI: 10.3389/fncel.2022.888232] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Löscher W, Howe CL. Molecular Mechanisms in the Genesis of Seizures and Epilepsy Associated With Viral Infection. Front Mol Neurosci 2022;15:870868. [DOI: 10.3389/fnmol.2022.870868] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Kitchen LC, Berman M, Halper J, Chazot P. Rationale for 1068 nm Photobiomodulation Therapy (PBMT) as a Novel, Non-Invasive Treatment for COVID-19 and Other Coronaviruses: Roles of NO and Hsp70. IJMS 2022;23:5221. [DOI: 10.3390/ijms23095221] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
18 Fabbri VP, Riefolo M, Lazzarotto T, Gabrielli L, Cenacchi G, Gallo C, Aspide R, Frascaroli G, Liguori R, Lodi R, Tonon C, D’errico A, Foschini MP. COVID-19 and the Brain: The Neuropathological Italian Experience on 33 Adult Autopsies. Biomolecules 2022;12:629. [DOI: 10.3390/biom12050629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Chiang W, Stout A, Yanchik-slade F, Li H, Nilsson B, Gelbard H, Krauss T. A Quantum Dot Biomimetic for SARS-CoV-2 to Interrogate Dysregulation of the Neurovascular Unit Relevant to Brain Inflammation.. [DOI: 10.1101/2022.04.20.488933] [Reference Citation Analysis]
20 Che Mohd Nassir CMN, Zolkefley MKI, Ramli MD, Norman HH, Abdul Hamid H, Mustapha M. Neuroinflammation and COVID-19 Ischemic Stroke Recovery—Evolving Evidence for the Mediating Roles of the ACE2/Angiotensin-(1–7)/Mas Receptor Axis and NLRP3 Inflammasome. IJMS 2022;23:3085. [DOI: 10.3390/ijms23063085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Ihunwo AO, Perego J, Martino G, Vicenzi E, Panina-bordignon P. Neurogenesis and Viral Infection. Front Immunol 2022;13:826091. [DOI: 10.3389/fimmu.2022.826091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
22 Zalpoor H, Akbari A, Samei A, Forghaniesfidvajani R, Kamali M, Afzalnia A, Manshouri S, Heidari F, Pornour M, Khoshmirsafa M, Aazami H, Seif F. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies. Cell Mol Biol Lett 2022;27:10. [PMID: 35109786 DOI: 10.1186/s11658-022-00311-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 26.0] [Reference Citation Analysis]
23 O. A. Gomazkov. Neurotropism as a Mechanism of the Damaging Action of Coronavirus. Biol Bull Rev 2022;12. [ DOI: 10.1134/S2079086422060044] [Reference Citation Analysis]
24 Kamchatnov PR, Cheremin RA, Skipetrova LA, Chugunov AV. Neurological Signs of Postcovid Syndrome. Neurosci Behav Physiol 2022;52:968-75. [PMID: 36589208 DOI: 10.1007/s11055-022-01324-1] [Reference Citation Analysis]
25 Kamchatnov P, Cheremin R, Skipetrova L, Chugunov A. Neurological manifestations of postcovid syndrome. Z nevrol psikhiatr im S S Korsakova 2022;122:7. [DOI: 10.17116/jnevro20221220317] [Reference Citation Analysis]
26 Katunina EA, Bezdolnyi YN, Shipilova NN. Possibilities of using amantadines in the setting of the novel coronavirus infection in patients with Parkinson's disease. RJTAO 2021;13:67-72. [DOI: 10.14412/2074-2711-2021-6-67-72] [Reference Citation Analysis]
27 Al-Kuraishy HM, Al-Gareeb AI, Qusti S, Alshammari EM, Gyebi GA, Batiha GE. Covid-19-Induced Dysautonomia: A Menace of Sympathetic Storm. ASN Neuro 2021;13:17590914211057635. [PMID: 34755562 DOI: 10.1177/17590914211057635] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
28 Leite AOF, Bento Torres Neto J, Dos Reis RR, Sobral LL, de Souza ACP, Trévia N, de Oliveira RB, Lins NAA, Diniz DG, Diniz JAP, Vasconcelos PFDC, Anthony DC, Brites D, Picanço Diniz CW. Unwanted Exacerbation of the Immune Response in Neurodegenerative Disease: A Time to Review the Impact. Front Cell Neurosci 2021;15:749595. [PMID: 34744633 DOI: 10.3389/fncel.2021.749595] [Reference Citation Analysis]
29 Alhuthail E, Stockley J, Coney A, Cooper B. Measurement of breathing in patients with post-COVID-19 using structured light plethysmography (SLP). BMJ Open Respir Res 2021;8:e001070. [PMID: 34642224 DOI: 10.1136/bmjresp-2021-001070] [Reference Citation Analysis]
30 Ondek K, Nasirishargh A, Dayton JR, Nuño MA, Cruz-Orengo L. Strain and sex differences in somatosensation and sociability during experimental autoimmune encephalomyelitis. Brain Behav Immun Health 2021;14:100262. [PMID: 34589768 DOI: 10.1016/j.bbih.2021.100262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Han Y, Yuan K, Wang Z, Liu WJ, Lu ZA, Liu L, Shi L, Yan W, Yuan JL, Li JL, Shi J, Liu ZC, Wang GH, Kosten T, Bao YP, Lu L. Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions. Transl Psychiatry 2021;11:499. [PMID: 34593760 DOI: 10.1038/s41398-021-01629-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
32 Theoharides TC. Ways to Address Perinatal Mast Cell Activation and Focal Brain Inflammation, including Response to SARS-CoV-2, in Autism Spectrum Disorder. J Pers Med 2021;11:860. [PMID: 34575637 DOI: 10.3390/jpm11090860] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
33 Pyne JD, Brickman AM. The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline. Neurodegener Dis 2021;21:1-23. [PMID: 34348321 DOI: 10.1159/000518581] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
34 Constant O, Barthelemy J, Bolloré K, Tuaillon E, Gosselet F, Chable-Bessia C, Merida P, Muriaux D, Van de Perre P, Salinas S, Simonin Y. SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects. Front Immunol 2021;12:697329. [PMID: 34386007 DOI: 10.3389/fimmu.2021.697329] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
35 Xu Q, Zhao B, Ye Y, Li Y, Zhang Y, Xiong X, Gu L. Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke. J Neuroinflammation 2021;18:123. [PMID: 34059091 DOI: 10.1186/s12974-021-02137-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
36 Perlmutter A. Immunological Interfaces: The COVID-19 Pandemic and Depression. Front Neurol 2021;12:657004. [PMID: 33967944 DOI: 10.3389/fneur.2021.657004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
37 Seehusen F, Clark JJ, Sharma P, Bentley EG, Kirby A, Subramaniam K, Giuliani SW, Hughes GL, Patterson EI, Michael BD, Owen A, Hiscox JA, Stewart JP, Kipar A. Neuroinvasion and neurotropism by SARS-CoV-2 variants in the K18-hACE2 mouse.. [DOI: 10.1101/2021.04.16.440173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
38 Theoharides TC, Cholevas C, Polyzoidis K, Politis A. Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue. Biofactors 2021;47:232-41. [PMID: 33847020 DOI: 10.1002/biof.1726] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 18.5] [Reference Citation Analysis]
39 Tavčar P, Potokar M, Kolenc M, Korva M, Avšič-Županc T, Zorec R, Jorgačevski J. Neurotropic Viruses, Astrocytes, and COVID-19. Front Cell Neurosci 2021;15:662578. [PMID: 33897376 DOI: 10.3389/fncel.2021.662578] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
40 Engin AB, Engin ED, Engin A. Current opinion in neurological manifestations of SARS-CoV-2 infection. Curr Opin Toxicol 2021;25:49-56. [PMID: 33817451 DOI: 10.1016/j.cotox.2021.03.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
41 Ramos AJ. Brain angiotensin system: a new promise in the management of epilepsy? Clin Sci (Lond) 2021;135:725-30. [PMID: 33729497 DOI: 10.1042/CS20201296] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
42 Amruta N, Chastain WH, Paz M, Solch RJ, Murray-Brown IC, Befeler JB, Gressett TE, Longo MT, Engler-Chiurazzi EB, Bix G. SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders. Cytokine Growth Factor Rev 2021;58:1-15. [PMID: 33674185 DOI: 10.1016/j.cytogfr.2021.02.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 40] [Article Influence: 16.5] [Reference Citation Analysis]
43 Gonçalves de Andrade E, Šimončičová E, Carrier M, Vecchiarelli HA, Robert MÈ, Tremblay MÈ. Microglia Fighting for Neurological and Mental Health: On the Central Nervous System Frontline of COVID-19 Pandemic. Front Cell Neurosci 2021;15:647378. [PMID: 33737867 DOI: 10.3389/fncel.2021.647378] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
44 Fakhri S, Piri S, Majnooni MB, Farzaei MH, Echeverría J. Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach. Front Pharmacol 2020;11:621099. [PMID: 33708124 DOI: 10.3389/fphar.2020.621099] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
45 Poliner D, Chang WW. COVID-19 Neurologic Illnesses. Critical Care of COVID-19 in the Emergency Department 2021. [DOI: 10.1007/978-3-030-85636-6_14] [Reference Citation Analysis]
46 Bodnar B, Patel K, Ho W, Luo JJ, Hu W. Cellular mechanisms underlying neurological/neuropsychiatric manifestations of COVID-19. J Med Virol 2021;93:1983-98. [PMID: 33300152 DOI: 10.1002/jmv.26720] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
47 Alexeeva NT, Sokolov DA, Nikityuk DB, Klochkova SV, Kvaratskheliya AG. Molecular and cellular mechanisms of central nervous system alteration in COVID-19. Žurnal anatomii i gistopatologii 2020;9:72-85. [DOI: 10.18499/2225-7357-2020-9-3-72-85] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]